These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32186823)

  • 21. Challenges in the treatment of Rheumatoid Arthritis.
    Conigliaro P; Triggianese P; De Martino E; Fonti GL; Chimenti MS; Sunzini F; Viola A; Canofari C; Perricone R
    Autoimmun Rev; 2019 Jul; 18(7):706-713. PubMed ID: 31059844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Diagnosis and Treatment of Rheumatoid Arthritis.
    Littlejohn EA; Monrad SU
    Prim Care; 2018 Jun; 45(2):237-255. PubMed ID: 29759122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extra-articular manifestations and complications of rheumatoid arthritis.
    Young A; Koduri G
    Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):907-27. PubMed ID: 17870035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review.
    Giollo A; Bissell LA; Buch MH
    Expert Opin Drug Saf; 2018 Jul; 17(7):697-708. PubMed ID: 29871535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe rheumatoid valvular heart disease.
    Anaya JM
    Clin Rheumatol; 2006 Sep; 25(5):743-5. PubMed ID: 16249828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents.
    Atzeni F; Talotta R; Masala IF; Gerardi MC; Casale R; Sarzi-Puttini P
    Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):500-510. PubMed ID: 31174819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compound heterozygosity of HLA-DR4 and DR1 antigens in Asian Indians increases the risk of extra-articular features in rheumatoid arthritis.
    Agrawal S; Aggarwal A; Dabadghao S; Naik S; Misra R
    Br J Rheumatol; 1995 Jan; 34(1):41-4. PubMed ID: 7881837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects.
    Xue Y; Cohen JM; Wright NA; Merola JF
    Am J Clin Dermatol; 2016 Apr; 17(2):147-62. PubMed ID: 26649439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between rheumatoid arthritis and primary biliary cirrhosis.
    Caramella C; Avouac J; Sogni P; Puéchal X; Kahan A; Allanore Y
    Joint Bone Spine; 2007 May; 74(3):279-81. PubMed ID: 17369071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience.
    Fantò M; Peragallo MS; Pietrosanti M; Di Rosa R; Picchianti Diamanti A; Salemi S; D'Amelio R
    Intern Emerg Med; 2016 Feb; 11(1):31-40. PubMed ID: 26099279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment.
    Smith MD; Weedon H; Papangelis V; Walker J; Roberts-Thomson PJ; Ahern MJ
    Rheumatology (Oxford); 2010 May; 49(5):862-75. PubMed ID: 20147446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extra-articular rheumatoid arthritis.
    Turesson C
    Curr Opin Rheumatol; 2013 May; 25(3):360-6. PubMed ID: 23425964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extra-articular Manifestations in Rheumatoid Arthritis.
    Cojocaru M; Cojocaru IM; Silosi I; Vrabie CD; Tanasescu R
    Maedica (Bucur); 2010 Dec; 5(4):286-91. PubMed ID: 21977172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheumatoid arthritis. Targeted interventions can minimize joint destruction.
    Williams EA; Fye KH
    Postgrad Med; 2003 Nov; 114(5):19-28. PubMed ID: 14650090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune thyroid disease and rheumatoid arthritis: relationship and the role of genetics.
    Lazúrová I; Jochmanová I; Benhatchi K; Sotak S
    Immunol Res; 2014 Dec; 60(2-3):193-200. PubMed ID: 25427993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Onset of myasthenia gravis in a patient affected by rheumatoid arthritis never treated with disease-modifying anti-rheumatic drugs.
    Coaccioli S; Ponteggia F; Di Cato L; Allegra A; Puxeddu A
    Panminerva Med; 1999 Jun; 41(2):135-7. PubMed ID: 10479912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effective analysis of disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
    Syngle A; Kaur S; Verma I; Syngle T; Syngle V
    Clin Rheumatol; 2017 Aug; 36(8):1715-1720. PubMed ID: 28634699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging trends in diagnosis and treatment of rheumatoid arthritis.
    Birch JT; Bhattacharya S
    Prim Care; 2010 Dec; 37(4):779-92, vii. PubMed ID: 21050958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New understanding and approaches to treatment in rheumatoid arthritis.
    Tayar JH; Suarez-Almazor ME
    Br Med Bull; 2010; 94():201-14. PubMed ID: 20200013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis.
    Haibel H; Specker C
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S159-63. PubMed ID: 19822065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.